Skip to main content
Signal8
Colleran David profile photo

David Colleran

CIK: 0001646558

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)6 (40.0%)

Derivative conversions

Awards (A)3 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)6 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Anika Therapeutics, Inc. logo
ANIK

Anika Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 15, 2026
    Exercise(M)
    Direct
    6.4K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 15, 2026
    Tax Payment(F)
    Direct
    1.9K shares at avg. $14.20$27K
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 14, 2026
    Exercise(M)
    Direct
    9.4K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 14, 2026
    Tax Payment(F)
    Direct
    4.2K shares at avg. $14.20$59K
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 14, 2026
    Award(A)
    Direct
    4.7K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 9, 2026
    Tax Payment(F)
    Direct
    1.9K shares at avg. $14.96$29K
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 9, 2026
    Exercise(M)
    Direct
    5.5K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 17, 2025
    Tax Payment(F)
    Direct
    1.9K shares at avg. $15.91$30K
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 17, 2025
    Exercise(M)
    Direct
    6.4K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 14, 2025
    Award(A)

    Restricted Stock Unit

    Direct
    13.7K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 14, 2025
    Award(A)

    Restricted Stock Unit

    Direct
    28.2K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 11, 2025
    Exercise(M)
    Direct
    7.7K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 11, 2025
    Tax Payment(F)
    Direct
    2.3K shares at avg. $16.79$38K
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 10, 2025
    Tax Payment(F)
    Direct
    1.6K shares at avg. $16.62$27K
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Mar 10, 2025
    Exercise(M)
    Direct
    5.5K shares-

1-15 of 15

About Colleran David

Colleran David (SEC CIK 0001646558) files insider reports with the SEC as EVP, General Counsel, Corp Sec of Anika Therapeutics, Inc. (ANIK).

Signal8 holds 5 ownership filings by Colleran David, all Form 4s, filed between Mar 11, 2025 and Mar 17, 2026. Those filings report 15 transactions, from Mar 10, 2025 to Mar 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Colleran David's filings is in BEDFORD, MA.

Recent filings by Colleran David

  • Mar 15, 2026: Option exercise of ANIK shares (Form 4, code M).
  • Mar 15, 2026: Tax withholding of ANIK shares (Form 4, code F).
  • Mar 14, 2026: Option exercise of ANIK shares (Form 4, code M).
  • Mar 14, 2026: Tax withholding of ANIK shares (Form 4, code F).
  • Mar 14, 2026: Grant or award of ANIK shares (Form 4, code A).

Other insiders filing for Anika Therapeutics, Inc. (ANIK)

How to read Form 4 transaction codes